Molecular Templates, Inc.
NASDAQ:MTEM
1.34 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Molecular Templates, Inc. |
Symbool | MTEM |
Munteenheid | USD |
Prijs | 1.36 |
Beurswaarde | 8,954,077 |
Dividendpercentage | 0% |
52-weken bereik | 1 - 6.93 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Eric E. Poma Ph.D. |
Website | https://www.mtem.com |
An error occurred while fetching data.
Over Molecular Templates, Inc.
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)